FDA warns Pita Pan Bakery that ready-to-eat pita, bagels and challah were made under insanitary conditions and had undeclared allergens.
What happened
FDA inspected the ready-to-eat food manufacturing facility from May 28, 2025 to June 11, 2025 and found serious violations of federal food manufacturing and preventive-control rules, including allergen cross-contact, contamination risks, poor hygiene, and hard-to-clean equipment. FDA also found that labels for Jerusalem Bagel, Sesame Pita Bread, and Challah Sesame Bread did not declare wheat or sesame allergens. The company had not responded to the Form FDA 483 (the inspection observations form) by the time of the letter.
What FDA found
The company did not clean and sanitize shared equipment and utensils often enough to prevent allergen cross-contact and contamination, including between egg-containing challah and egg-free bagel dough.
21 CFR 117.35(d)The company did not use controls needed to keep ready-to-eat foods from being contaminated by dust, flour, damaged ceilings, pests, or open doors.
21 CFR 117.80(c)(2)Employees did not follow hygiene practices, such as washing hands, changing gloves, covering beard hair, and keeping personal items out of processing areas.
21 CFR 117.10(b)Equipment and utensils were not cleanable or well maintained, including plywood trays with food debris, cracked wooden tables, taped equipment, and a frayed oven flap touching pita.
21 CFR 117.40(a)Labels for Jerusalem Bagel, Sesame Pita Bread, and Challah Sesame Bread did not declare wheat or sesame as major food allergens.
section 403(w) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. ยง 343(w)]
What FDA wants
FDA asks the company to notify it in writing within 15 working days of receipt about the specific steps taken to correct the violations, prevent recurrence, and provide related documents; if corrections cannot be completed within 15 days, the company must state why and give a timeframe. FDA also notes that the facility has not submitted a required qualified-facility attestation.
Who should pay attention
- retailers and food-service buyers of ready-to-eat baked goods
- brands that share bakery equipment between allergen-containing and allergen-free products
- consumers with wheat or sesame allergies
This is a summary. Read the original letter on fda.gov.